Skip to main content
. 2024 Nov 26;12(33):6620–6628. doi: 10.12998/wjcc.v12.i33.6620

Table 1.

Clinicopathological characteristics, n (%)

Variable
Non-MCS (n = 382)
MCS (n = 110)
P value
Sex 0.4106
    Male 241 (63.1) 64 (58.2)
    Female 141 (36.9) 46 (41.8)
Age (years)
    < 60 115 (30.1) 35 (31.8) 0.8209
    ≥ 60 267 (69.9) 75 (68.25)
Intestinal rapture 14 (3.7) 12 (10.95) 0.0059
Diabetic 89 (23.3) 26 (23.6) 1.0000
Immunotherapy 153 (40.0) 45 (40.9) 0.9592
Neoadjuvant therapy 153 (40.0) 56 (50.9) 0.0548
Suture dislodgement 42 (11.0) 63 (57.3) < 0.0001
Incision infection 49 (12.8) 42 (38.2) < 0.0001
BMI (kg/m2)
    < 24 257 (67.3) 54 (49.1) 0.0007
    ≥ 24 125 (32.7) 56 (50.9)
Stoma site
    Ileum 228 (59.7) 83 (75.4) 0.0036
    Colon 154 (40.3) 27 (24.6)
Elevated intra-abdominal pressure 183 (47.9) 65 (59.1) 0.0501
Hemoglobin level
    ≤ 90 82 (21.5) 34 (30.9) 0.0501
    > 90 300 (78.5) 76 (69.1)
Albumin level
    ≤ 28 54 (14.1) 34 (30.9) < 0.0001
    > 28 328 (85.9) 76 (69.1)

BMI: Body mass index; MCS: Mucocutaneous separation.